Bromazepam is an anxiolytic medication indicated to reduce anxiety and control mood changes in adults.It is indicated for the relief of symptoms associated with anxiety syndrome.In addition, it is also indicated in the treatment of agitation and anxiety caused by psychiatric disorders such as schizophrenia or mood problems in adults.This medicine is manufactured by the Roche laboratory and may be sold under the brand name Lexotan in the form of 3 or 6 mg tablets or oral solution.
How to take
The use of Lexotan should only be made by doctor’s appointment and the dose varies according to the patient’s need. However, usually 1.5 to 3 mg is indicated up to 3 times daily.These doses are general recommendations and the dose should be prescribed by the physician.In addition, the maximum daily dose is 12 mg up to 3 times daily, but this dose is only used within the hospital.
Side effects;What evils can it cause me?
However, some side effects, such as tiredness, drowsiness and, in rare cases, and muscle relaxation.Using this medication can cause tiredness, drowsiness and muscle relaxation.
The use of this medication is contraindicated in case of allergy,hypersensitivity to benzodiazepines, severe respiratory insufficiency, severe hepatic insufficiency or sleep apnea syndrome.In addition, this medication should not be used in pregnant or breast feeding women.
Adverse Reactions of Bromazepam
Bromazepam is well tolerated at therapeutic doses. The following undesirable effects you must know.
Mental confusion, emotional disturbances.Disorders of libido have been reported occasionally.
Restlessness, agitation, irritability, aggression, delusions, anger , nightmares, hallucinations, psychosis , inappropriate behavior and other adverse behavioral effects may occur after the administration of benzodiazepines or similar agents.
Nervous System Disorders
Drowsiness, headache, dizziness, decreased alertness, ataxia (lack of motor coordination). These phenomena occur predominantly at the beginning of treatment and usually disappear after repeated doses.
Diplopia (double vision) occurs predominantly at the beginning of therapy and usually disappears after repeated doses.
Gastrointestinal disorders have been reported occasionally.
Skin and Subcutaneous Tissue Disorders
Skin reactions have been reported occasionally.
Musculoskeletal and Connective Tissue Disorders
Muscle weakness occurs predominantly at the start of therapy and usually disappears after repeated doses.
General disorders and administration site conditions
Fatigue occurs predominantly at the start of therapy and usually disappears after repeated doses.